Literature DB >> 1696322

Activity of fludarabine monophosphate in patients with advanced mycosis fungoides: a Southwest Oncology Group study.

D D Von Hoff1, S Dahlberg, R J Hartstock, H J Eyre.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696322     DOI: 10.1093/jnci/82.16.1353

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

Review 1.  Cutaneous T-cell lymphomas: a review of new discoveries and treatments.

Authors:  Tara Bloom; Timothy M Kuzel; Christiane Querfeld; Joan Guitart; Steven T Rosen
Journal:  Curr Treat Options Oncol       Date:  2012-03

Review 2.  Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.

Authors:  J C Adkins; D H Peters; A Markham
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 3.  Fludarabine. A review of its pharmacological properties and therapeutic potential in malignancy.

Authors:  S R Ross; D McTavish; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

4.  Phase II study of fludarabine phosphate for gastric adenocarcinoma. An Illinois Cancer Center trial.

Authors:  L J Kilton; J B Ashenhurst; J L Wade; R L Schilsky; G Shiomoto; R R Blough; S L French; A B Benson
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

Review 5.  Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma.

Authors:  G Rodriguez
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

Review 6.  Current and emerging treatment strategies for cutaneous T-cell lymphoma.

Authors:  Frederick Lansigan; Francine M Foss
Journal:  Drugs       Date:  2010-02-12       Impact factor: 9.546

Review 7.  Fludarabine in the management of malignant lymphomas.

Authors:  W Hiddemann; C Pott-Hoeck
Journal:  Drugs       Date:  1994       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.